Tada Y - Search Results

1

Pyrrolinone derivatives as a new class of P2X3 receptor antagonists Part 2: Discovery of orally bioavailable compounds.

Tobinaga H, Kameyama T, Asahi K, Horiguchi T, Oohara M, Tada Y, Fuchino K, Jikihara S, Endoh T, Kurihara N, Kanda Y, Ogawa M, Tamura N, Yagi S, Taniguchi E, Takahara Y, Shimada S, Takeyama C, Yamamoto S, Shinohara S, Kai H. Tobinaga H, et al. Among authors: tada y. Bioorg Med Chem Lett. 2019 Mar 1;29(5):688-693. doi: 10.1016/j.bmcl.2019.01.039. Epub 2019 Feb 1. Bioorg Med Chem Lett. 2019. PMID: 30728111

2

Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives.

Tobinaga H, Kameyama T, Asahi K, Horiguchi T, Oohara M, Taoda Y, Hata K, Hasegawa T, Tada Y, Kurihara N, Kanda Y, Yagi S, Tomari M, Tanaka Y, Takahashi F, Taniguchi E, Takahara Y, Shimada S, Takeyama C, Yamamoto S, Shinohara S, Kai H. Tobinaga H, et al. Among authors: tada y. Bioorg Med Chem Lett. 2020 Dec 15;30(24):127636. doi: 10.1016/j.bmcl.2020.127636. Epub 2020 Oct 22. Bioorg Med Chem Lett. 2020. PMID: 33132115

3

Selective CB2 agonists with anti-pruritic activity: discovery of potent and orally available bicyclic 2-pyridones.

Kusakabe K, Iso Y, Tada Y, Sakagami M, Morioka Y, Chomei N, Shinonome S, Kawamoto K, Takenaka H, Yasui K, Hamana H, Hanasaki K. Kusakabe K, et al. Among authors: tada y. Bioorg Med Chem. 2013 Jun 1;21(11):3154-63. doi: 10.1016/j.bmc.2013.03.030. Epub 2013 Mar 30. Bioorg Med Chem. 2013. PMID: 23623258

4

Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.

Yano S, Kazuno H, Suzuki N, Emura T, Wierzba K, Yamashita J, Tada Y, Yamada Y, Fukushima M, Asao T. Yano S, et al. Among authors: tada y. Bioorg Med Chem. 2004 Jul 1;12(13):3431-41. doi: 10.1016/j.bmc.2004.04.036. Bioorg Med Chem. 2004. PMID: 15186829

5

Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists.

Kusakabe K, Tada Y, Iso Y, Sakagami M, Morioka Y, Chomei N, Shinonome S, Kawamoto K, Takenaka H, Yasui K, Hamana H, Hanasaki K. Kusakabe K, et al. Among authors: tada y. Bioorg Med Chem. 2013 Apr 1;21(7):2045-55. doi: 10.1016/j.bmc.2013.01.006. Epub 2013 Jan 16. Bioorg Med Chem. 2013. PMID: 23395112

6

Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase.

Yano S, Kazuno H, Sato T, Suzuki N, Emura T, Wierzba K, Yamashita J, Tada Y, Yamada Y, Fukushima M, Asao T. Yano S, et al. Among authors: tada y. Bioorg Med Chem. 2004 Jul 1;12(13):3443-50. doi: 10.1016/j.bmc.2004.04.046. Bioorg Med Chem. 2004. PMID: 15186830

7

Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.

Nakano H, Saito N, Parker L, Tada Y, Abe M, Tsuganezawa K, Yokoyama S, Tanaka A, Kojima H, Okabe T, Nagano T. Nakano H, et al. Among authors: tada y. J Med Chem. 2012 Jun 14;55(11):5151-64. doi: 10.1021/jm3001289. Epub 2012 May 17. J Med Chem. 2012. PMID: 22540945

8

The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin.

Usui T, Watanabe H, Nakayama H, Tada Y, Kanoh N, Kondoh M, Asao T, Takio K, Watanabe H, Nishikawa K, Kitahara T, Osada H. Usui T, et al. Among authors: tada y. Chem Biol. 2004 Jun;11(6):799-806. doi: 10.1016/j.chembiol.2004.03.028. Chem Biol. 2004. PMID: 15217613

9

Global Delphi consensus on treatment goals for generalised pustular psoriasis.

Barker JN, Casanova E, Choon SE, Foley P, Fujita H, Gonzalez C, Gooderham M, Marrakchi S, Puig L, Romiti R, Thaçi D, Zheng M, Strober B; Partnering for Innovation and Excellence in Rare Skin Diseases (PIONEERS®) Working Group and the DELPHI Panel. Barker JN, et al. Br J Dermatol. 2025 Jan 23:ljae491. doi: 10.1093/bjd/ljae491. Online ahead of print. Br J Dermatol. 2025. PMID: 39844356

10

A Case of Small-Cell Lung Cancer With Novel Anaplastic Lymphoma Kinase Gene Rearrangement That Developed Intradural Extramedullary Spinal Metastases With Myelitis.

Mizuno Y, Tada Y, Uehara T, Yamashita S, Murai H. Mizuno Y, et al. Among authors: tada y. Cureus. 2024 Dec 9;16(12):e75369. doi: 10.7759/cureus.75369. eCollection 2024 Dec. Cureus. 2024. PMID: 39781173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,633 results

Search Page

Filters